Skip to main content

Exome Asset Management LLC

Source: SEC Form 13F · as of Mar 2026

Exome Asset Management LLC holds 36 biotech & pharma companies tracked by BioSniper, totaling $147.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

36

Total value held

$147.8M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Praxis Precision Medicines, Inc. (PRAX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
PRAXPraxis Precision Medicines, Inc.45,469$14.6M
COGTCogent Biosciences, Inc.278,533$10.7M
ELVNEnliven Therapeutics, Inc.220,091$8.6M
IONSIONIS PHARMACEUTICALS INC110,064$8.3M
GHGuardant Health Inc.82,736$7.6M
CYTKCYTOKINETICS INC103,718$6.8M
LLYELI LILLY & Co7,012$6.4M
ALMSALUMIS INC.279,176$6.2M
BBIOBridgeBio Pharma, Inc.67,492$5.0M
VERAVera Therapeutics, Inc.114,991$4.6M
INSMINSMED Inc26,651$4.4M
ELVElevance Health Inc.14,677$4.3M
AGIOAGIOS PHARMACEUTICALS, INC.125,060$4.2M
UTHRUNITED THERAPEUTICS Corp7,053$4.2M
MLTXMoonLake Immunotherapeutics215,376$4.0M
RYTMRHYTHM PHARMACEUTICALS, INC.40,581$3.5M
UNHUnitedHealth Group Incorporated Common Stock (DE)12,862$3.5M
APLSApellis Pharmaceuticals, Inc.85,517$3.4M
VSTMVerastem, Inc.636,700$3.4M
ALKSAlkermes plc.84,103$3.0M
GLUEMonte Rosa Therapeutics, Inc.179,484$3.0M
ARWRARROWHEAD PHARMACEUTICALS, INC.45,721$2.9M
CBIOCRESCENT BIOPHARMA, INC.153,191$2.8M
RLAYRelay Therapeutics, Inc.278,302$2.8M
MAZEMaze Therapeutics, Inc.88,510$2.6M
CTMXCytomX Therapeutics, Inc.521,468$2.5M
AVTXAvalo Therapeutics, Inc.159,341$2.4M
CRBPCorbus Pharmaceuticals Holdings, Inc.234,136$2.2M
SLNOSOLENO THERAPEUTICS INC61,673$2.1M
LQDALiquidia Corp45,796$1.7M
ZBIOZenas BioPharma, Inc.80,730$1.6M
NBPNovaBridge Biosciences576,960$1.4M
FDMT4D Molecular Therapeutics, Inc.130,564$1.2M
PALIPALISADE BIO, INC.600,000$1.1M
LPCNLipocine Inc.60,861$486K
ABUSArbutus Biopharma Corp75,484$340K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.